Main Session: Advances in the Management of Patients with Urothelial Carcinomas of the Bladder

What are the differences between immunotherapeutic and chemotherapeutic agents?

Amishi Shah, MD

Amishi Shah, MD, on managing patients with urothelial carcinomas of the bladder.

Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here